Vértigo por covid
What to do with a patient who had covid six months ago and since then has presented a picture of instability or vertigo. Evaluated by ENT and Neurology, without pathology and with normal brain MRI?
persistent vertigo
I have quite a few patients, and also I myself am sufferring from, persistent mild vertigo after covid 19. Any thoughts on how to manage this?
secuela de surdez parcial (90%) del oido derecho .
hombre de 51 años tuvo Covid-19 com síntomas de fiebre, dolor en el cuerpo , y apresento após 30 dias perdida de acuidad auditiva del 90% en el oído derecho, acompañada de zumbidos y vértigos.
-
General Medicine
United Kingdom
Mukta or Mucta varti is an ayurveda treatment for hypertension. I met someone on a post-grad course who had suffered hypertension with an inability to take any of the normal prescription drugs; nausea, vomiting, vertigo from the prescription meds. How he found out about the mukta vati I have no idea. I have only ever used it with one patient and it was amazing
__reactions__ -
-
Occupational Medicine
Spain
Tengo un paciente que presenta afectación neurológica a nivel periférico, central y autónomo tras vacunación (tercera dosis, moderna).
Después de varios ingresos hospitalarios por este hecho le han detectado una neuropatía de fibras finas que habría generado una polineuropatía y disautonomía.
Está todavía en estudio, pero presenta trastornos del SNA (hipotensión, taquicardia, problemas gastrointestinales y genitourinarios...), hipofunción vestibular con trastornos del equilibrio y vértigos recurrentes e invalidantes. Así como pérdida de memoria y déficit atencional.
Se sospechó temprano de enfermedad desmielinizante ya que también presenta debilidad muscular severa, pero la RM fue normal. Presenta cambios bilaterales de las vías cordonales a nivel de la médula en los potenciales evocados y una disminución de la amplitud del potencial motor a EDB derecha y significativamente más baja respecto al lado izquierdo, en la electromiografía.
Está en contacto con otras personas afectadas que presentan lesiones desmielinizantes y otras alteraciones neurológicas Agradecería opiniones.
__reactions__ -
-
Occupational Medicine
Spain
Tengo una paciente que a causa de la vacunación cont Covid, presenta cuadro de fatiga muscular, cansancio, dolores musculares, astenia, y ahora ha empezado con vértigos que le impiden deambular, el neurólogo le ha diagnósticado un cuadro similar al Síndrome de Gullian
Barré pero sin estar seguro de ella. La paciente lleva 1 año de baja laboral, porque los síntomas le impiden hacer vida laboral y social. Que opinais de estos efectos secundarios a la vacuna?
__reactions__
Guidelines Developed for ED Management of New Dizziness, Vertigo
THURSDAY, June 8, 2023 (HealthDay News) -- In a consensus statement published in the May issue of Academic Emergency Medicine, guidelines are presented for the emergency department management of patients with new dizziness or vertigo without an obvious medical or neurological cause.
Jonathan A. Edlow, M.D., from Harvard Medical School in Boston, and colleagues developed guidelines relating to adults with acute dizziness and vertigo in the emergency department. Fifteen evidence-based recommendations were developed based on the timing and triggers of the dizziness.
The authors noted that emergency clinicians should receive training in bedside physical examination techniques for patients with acute vestibular syndrome (AVS) and diagnostic and therapeutic maneuvers for benign paroxysmal positional vertigo (BPPV) as an overarching recommendation. For patients with AVS, to help distinguish central from peripheral causes, HINTS (head impulse-nystagmus-test of skew) should be used in patients with nystagmus; finger rub can further aid with excluding stroke in patients with nystagmus; and severity of gait unsteadiness should be used in patients without nystagmus. Brain computed tomography should not be used. Routine magnetic resonance imaging should not be used as a first-line test if a clinician trained in HINTS is available, but can be used as a confirmatory test for patients with central or equivocal HINTS examination.
"The good news is with a bit of training and the algorithmic approach discussed in GRACE-3 [Guidelines for Reasonable and Appropriate Care in the Emergency Department 3], we can learn to take much better care of these patients, faster, with more confidence and less imaging," Edlow said in a statement.
Several authors disclosed ties to industry.
Copyright © 2020 HealthDay. All rights reserved.
Vestibular Dysfunction May Be Modifiable Risk Factor for Cognitive Decline
MONDAY, May 8, 2023 (HealthDay News) -- Vestibular dysfunction is a potentially modifiable risk factor for cognitive decline, according to a study published online April 4 in Frontiers in Neuroscience.
Jiake Zhong, from the Beijing Tsinghua Changgung Hospital and School of Clinical Medicine at Tsinghua University, and colleagues evaluated the cognitive functions, vertigo symptoms and related physical, functional, and emotional effects of patients with Meniere disease (MD) before and after treatment (three, six, and 12 months). Outcomes were assessed using the Montreal Cognitive Assessment and Dizziness Handicap Inventory.
The researchers found that before therapy, cognitive function (especially in memory) was impaired in MD patients compared with healthy controls. Cognitive impairment improved after effective therapy and was related to the severity of vertigo, particularly in functional and physical impacts.
"Given that MD patients in the middle and late stages often have progressive hearing loss that is challenging to recover from, the vestibular function is more likely to be a potentially modifiable risk factor for cognitive decline," the authors write. "In the future, we will conduct more objective and comprehensive evaluations, such as the number, duration, and frequency of vertigo attacks, cognitive tasks in various subdomains, and neuro-electrophysiological indexes on the patients and further explore the relationships between them with larger samples."
Copyright © 2020 HealthDay. All rights reserved.
Most Patients With Acute Low-Tone Hearing Loss Have Recovery
WEDNESDAY, April 5, 2023 (HealthDay News) -- For patients with acute low-tone hearing loss (ALHL) without vertigo, partial or complete recovery is reported frequently, although recurrence seems to be relatively common, according to a review published online March 7 in The Laryngoscope.
Ryan J. Huang, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues conducted a scoping review of the literature to examine recovery from hearing loss, recurrence and/or fluctuation of hearing loss, and progression to Meniere disease among patients presenting with ALHL without vertigo. Data were included from 41 studies.
The researchers identified extensive heterogeneity between studies with respect to defining ALHL, treatment methods, and follow-up time. Partial or complete recovery of hearing was reported in the majority of patients (>50 percent) in most of the cohorts (39 of 40), although reports of recurrence were relatively common. Progression to Meniere disease occurred rarely. In six of eight studies, shorter time from onset of symptoms to treatment predicted better hearing outcomes.
"While the literature suggests that the majority of patients with ALHL appear to experience hearing improvement, recurrence and/or fluctuation are common," the authors write. "Additional studies and randomized controlled trials utilizing standardized criteria for diagnosis, study inclusion, and hearing outcome are needed to determine the natural history and ideal treatment for ALHL."
One author disclosed serving on the surgical advisory boards for Med-El and Advanced Bionics.
Copyright © 2020 HealthDay. All rights reserved.
